Bile Duct Cancer Market Research Report – Global Forecast Till 2027

Bile Duct Cancer Market Research Report, By Type (Intrahepatic, Extrahepatic), Diagnosis (Blood Tests, Abdominal Imaging, Surgery), By Treatment (Chemotherapy, Radiotherapy), By End User (Hospital& Clinics, Academic Institutes) - Global Forecast till 2027

ID: MRFR/Pharma/3319-HCR | February 2021 | Region: Global | 90 Pages         

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Bile Duct Cancer Market, by Type

6.1 Introduction

6.2 Intrahepatic

6.2.1 Market Estimates & Forecast, 2020 – 2027

6.3 Extrahepatic

6.3.1 Market Estimates & Forecast, 2020 – 2027

6.4 Others

Chapter 7. Global Bile Duct Cancer Market, by Diagnosis

7.1 Introduction

7.2 Blood Tests

7.2.1 Market Estimates & Forecast, 2020 – 2027

7.3 Abdominal imaging

Market Estimates & Forecast, 2020 – 2027

7.3.1 Endoscopic retrograde cholangiopancreatography (ERCP)

7.3.2 Percutaneous transhepatic cholangiography (PTC)

7.3.3 Magnetic resonance cholangiopancreatography (MRCP)

7.3.4 Others

7.4 Surgery

7.4.1 Market Estimates & Forecast, 2020 – 2027

7.5 Others

7.5.1 Market Estimates & Forecast, 2020 – 2027

Chapter 8. Global Bile Duct Cancer Market, by Treatment

8.1 Introduction

8.2 Chemotherapy

Market Estimates & Forecast, 2020 – 2027

8.2.1 5-fluorouracil

8.2.2 Gemcitabine

8.2.3 Cisplatin

8.2.4 Others

8.3 Radiotherapy

8.3.1 Market Estimates & Forecast, 2020 – 2027

8.4 Others

8.4.1 Market Estimates & Forecast, 2020 – 2027

Chapter 9 Global Bile Duct Cancer Market, by End Users

9.1 Introduction

9.2 Hospitals & Clinics

9.2.1 Market Estimates & Forecast, 2020 – 2027

9.3 Academic Institutes

9.3.1 Market Estimates & Forecast, 2020 – 2027

9.4 Research Organizations

9.4.1 Market Estimates & Forecast, 2020 – 2027

9.5 Others

9.5.1 Market Estimates & Forecast, 2020 – 2027

Chapter 10. Global Bile Duct Cancer Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 US

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Pfizer Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 F. Hoffmann-La Roche Ltd

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Bristol-Myers Squibb Company

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Teva Pharmaceutical Industries Ltd.

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Eli Lilly and Company.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Sanofi

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Fresenius Kabi AG

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Mylan N.V.

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of cancer industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Bile Duct Cancer Industry Synopsis, 2020 – 2027

Table 2 Global Bile Duct Cancer Market Estimates and Forecast, 2020 – 2027, (USD Million)

Table 3 Global Bile Duct Cancer Market by Region, 2020 – 2027, (USD Million)

Table 4 Global Bile Duct Cancer Market by Types, 2020 – 2027, (USD Million)

Table 5 Global Bile Duct Cancer Market by Diagnosis, 2020 – 2027, (USD Million)

Table 6 Global Bile Duct Cancer Market by Treatment, 2020 – 2027, (USD Million)

Table 7 Global Bile Duct Cancer Market by End Users, 2020 – 2027, (USD Million)

Table 8 North America Bile Duct Cancer Market by Types, 2020 – 2027, (USD Million)

Table 9 North America Bile Duct Cancer Market by Diagnosis, 2020 – 2027, (USD Million)

Table 10 North America Bile Duct Cancer Market by Treatment, 2020 – 2027, (USD Million)

Table 11 North America Bile Duct Cancer Market by End Users, 2020 – 2027, (USD Million)

Table 12 US Bile Duct Cancer Market by Type, 2020 – 2027, (USD Million)

Table 13 US Bile Duct Cancer Market by Diagnosis, 2020 – 2027, (USD Million)

Table 14 US Bile Duct Cancer Market by Treatment, 2020 – 2027, (USD Million)

Table 15 US Bile Duct Cancer Market by End Users, 2020 – 2027, (USD Million)

Table 16 Canada Bile Duct Cancer Market by Type, 2020 – 2027, (USD Million)

Table 17 Canada Bile Duct Cancer Market by Diagnosis, 2020 – 2027, (USD Million)

Table 18 Canada Bile Duct Cancer Market by Treatment, 2020 – 2027, (USD Million)

Table 19 Canada Bile Duct Cancer Market by End Users, 2020 – 2027, (USD Million)

Table 20 South America Bile Duct Cancer Market by Type, 2020 – 2027, (USD Million)

Table 21 South America Bile Duct Cancer Market by Diagnosis, 2020 – 2027, (USD Million)

Table 22 South America Bile Duct Cancer Market by Treatment, 2020 – 2027, (USD Million)

Table 23 South America Bile Duct Cancer Market by End Users, 2020 – 2027, (USD Million)

Table 24 Europe Bile Duct Cancer Market by Type, 2020 – 2027, (USD Million)

Table 25 Europe Bile Duct Cancer Market by Diagnosis, 2020 – 2027, (USD Million)

Table 26 Europe Bile Duct Cancer Market by Treatment, 2020 – 2027, (USD Million)

Table 27 Europe Bile Duct Cancer Market by End Users, 2020 – 2027, (USD Million)

Table 28 Western Europe Bile Duct Cancer Market by Types, 2020 – 2027, (USD Million)

Table 29 Western Europe Bile Duct Cancer Market by Diagnosis, 2020 – 2027, (USD Million)

Table 30 Western Europe Bile Duct Cancer Market by Treatment, 2020 – 2027, (USD Million)

Table 31 Western Europe Bile Duct Cancer Market by End Users, 2020 – 2027, (USD Million)

Table 32 Eastern Europe Market by Type, 2020 – 2027, (USD Million)

Table 33 Eastern Europe Bile Duct Cancer Market by Diagnosis, 2020 – 2027, (USD Million)

Table 34 Eastern Europe Bile Duct Cancer Market by Treatment, 2020 – 2027, (USD Million)

Table 35 Eastern Europe Bile Duct Cancer Market by End Users, 2020 – 2027, (USD Million)

Table 36 Asia Pacific Bile Duct Cancer Market by Types, 2020 – 2027, (USD Million)

Table 37 Asia Pacific Bile Duct Cancer Market by Diagnosis, 2020 – 2027, (USD Million)

Table 38 Asia Pacific Bile Duct Cancer Market by Treatment, 2020 – 2027, (USD Million)

Table 39 Asia Pacific Bile Duct Cancer Market by End Users, 2020 – 2027, (USD Million)

Table 40 Middle East & Africa Bile Duct Cancer Market by Types, 2020 – 2027, (USD Million)

Table 41 Middle East & Africa Bile Duct Cancer Market by Diagnosis, 2020 – 2027, (USD Million)

Table 42 Middle East & Africa Bile Duct Cancer Market by Treatment, 2020 – 2027, (USD Million)

Table 43 Middle East & Africa Bile Duct Cancer Market by End Users, 2020 – 2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Bile Duct Cancer Market

Figure 3 Segmentation Market Dynamics for Global Bile Duct Cancer Market

Figure 4 Global Bile Duct Cancer Market Share, by Type 2020

Figure 5 Global Bile Duct Cancer Market Share, by Diagnosis 2020

Figure 6 Global Bile Duct Cancer Market Share, by Treatment 2020

Figure 7 Global Bile Duct Cancer Market Share, by End Users, 2020

Figure 8 Global Bile Duct Cancer Market Share, by Region, 2020

Figure 9 North America Bile Duct Cancer Market Share, by Country, 2020

Figure 10 Europe Bile Duct Cancer Market Share, by Country, 2020

Figure 11 Asia Pacific Bile Duct Cancer Market Share, by Country, 2020

Figure 12 Middle East & Africa Bile Duct Cancer Market Share, by Country, 2020

Figure 13 Global Bile Duct Cancer Market: Company Share Analysis, 2020 (%)

Figure 14 Pfizer Inc.: Key Financials

Figure 15 Pfizer Inc.: Segmental Revenue

Figure 16 Pfizer Inc.: Geographical Revenue

Figure 17 F. Hoffmann-La Roche Ltd: Key Financials

Figure 18 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 19 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 20 Bristol-Myers Squibb Company: Key Financials

Figure 21 Bristol-Myers Squibb Company: Segmental Revenue

Figure 22 Bristol-Myers Squibb Company: Geographical Revenue

Figure 23 Teva Pharmaceutical Industries Ltd.: Key Financials

Figure 24 Teva Pharmaceutical Industries Ltd.: Segmental Revenue

Figure 25 Teva Pharmaceutical Industries Ltd.: Geographical Revenue

Figure 26 Sanofi: Key Financials

Figure 27 Sanofi: Segmental Revenue

Figure 28 Sanofi: Geographical Revenue

Figure 29 Fresenius Kabi AG: Key Financials

Figure 30 Fresenius Kabi AG: Segmental Revenue

Figure 31 Fresenius Kabi AG: Geographical Revenue

Figure 32 Mylan N.V.: Key Financials

Figure 33 Mylan N.V.: Segmental Revenue

Figure 34 Mylan N.V.: Geographical Revenue


Bile Duct Cancer Market Speak to Analyst Request a Free Sample

Bile Duct Cancer Market overview


The bile duct is also called cholangiocarcinoma, a form of cancer in which the epithelial cells of a person get muted, which means they show epithelial differentiation in the bile duct. The Bile Duct Cancer Market Outlook shows the market will register a CAGR of 9.2% during the forecast period. The main reason for cancer is not known to anybody. Still, factors responsible for this are biliary stones, long-term inflammation in the liver, abnormalities in the bile duct such as cysts, infection with liver flukes parasite that causes infection in the bile duct. Some of the major symptoms of bile duct cancer are loss of appetite, weight loss, jaundice, abdominal pain, fever, etc., although the cancer is very rare and can affect inside and outside the liver. Due to the wrong diagnosis of cancer, the number seems low, but if the diagnosis is made properly, the number is getting higher day by day. It mostly affects patients above the age of sixty. Over the last ten years, the intrahepatic bile duct cancer cases increasing. Such increases in the relevance of the disease are propelling market growth. According to the research, in unites states, many people are still living with liver and bile duct cancer.


Covid-19 analysis 


COVID 19 has affected many business sectors, and the economy of several regions declined due to the effect. Pandemic affected the economy by directly affecting the production and demand, disrupting the distribution channel and having a severe financial impact on the global market. During the pandemic in June 2020, the national health institute announced covid 19 research initiatives through antibody testing. Continuous increasing population for cancer diagnosis during the period with have a positive impact on the market. As the demand for medical equipment increased and people visited hospitals more than before during the novel coronavirus spread, the market positively impacted the virus spread.


Chief Factors Existing In The Market  



  • Key drivers


Increased expenditure on the healthcare sector by the government and the consumers boosts the market growth. Rising infection like liver fluke will fuel the demand for the market, increasing the treatment of bile duct cancer impacting the bile duct cancer market. In addition to it, rising exposure to harmful chemicals for printing and other process is escalating the market. Awareness about cancer prevention and control increased public and private sector funding awareness. The steady introduction of technologically advanced medical equipment and devices is also expected to drive the growth of the bile duct cancer market. Bile Duct Cancer Market Trends should be flowed by the companies to improve the density of the consumers.



  • Market challenges


The challenges of the market are towards the market to improve the market with proper implementation. The time-consuming approach towards the diagnosis and treatment is a foremost challenging factor for the market. The new key players must change the challenges to growth factors in the forecast period.



  • Market opportunities


Several new programs are occurring towards the treatment of cancer to improve the current situation of cancer. Many types of research are taking place to find the drugs and other necessities of cancer to make it easier for the patients. With this, the advanced healthcare facilities by hospitals and clinics for cancer patients are also improving, which forms ample growth opportunities for the bile duct cancer market.



  • Market restraints


The market faces growth factors as well as restrains. Many restraints are impacting the market negatively. High cost and several processes for diagnosis and treatment of cancer are the main factors that limit the Bile Duct Cancer Market Value. The clinical trials for cancer patients are hampering the market.


Cumulative Evaluation Of The Market


The cumulative report shows a comprehensive study of the Bile Duct Cancer Market and its segments. It shows a holistic evaluation of the market, such as key segments, drivers, restraints, opportunities, and other factors playing a prominent role in the market. According to the Bile Duct Cancer Market Analysis, the market will register growth in the forecast period. People are getting concerned about their health and getting a diagnosis for the disease before it gets worse. Covid 19 impacted the market negatively due to cancer's growth of the population.


Market segmentation 



  • By type


The Bile Duct Cancer Market is classified into Intrahepatic and Extrahepatic based on the segment type. When the cancer formation happens inside the bile duct, it is known as intrahepatic bile duct cancer. In contrast, the extrahepatic is cancer formation in the hilum and distal region.



  • By diagnosis


The diagnosis is bifurcated into Blood Tests, Abdominal Imaging and Surgery. Abdominal imaging is further divided into endoscopic retrograde cholangiopancreatography (ERCP), percutaneous, transhepatic cholangiography(PTC), magnetic resonance cholangiopancreatography (MRCP), and others.



  • By treatment


 The sub-variables of treatment are Chemotherapy and Radiotherapy. The Bile Duct Cancer Market Size is fragmented into 5-fluorouracil, gemcitabine, cisplatin, and others based on the sub-segment chemotherapy.



  • By end-user


The Bile Duct Cancer Market is segregated into hospitals & Clinics, and Academic Institutes by the end-user segment. The hospital and clinic segment is expected to dominate the market as external beam radiation therapy is accepted for cholangiocarcinoma needs. By the end of 2025, the segment will have a dominating effect on the market. Each segment has its impact on the market and the global condition.


Regional analysis


The Bile Duct Cancer Market is analyzed in Asia Pacific, America, Europe, the middle east and Africa. America is dominating the market, and it is expected that it will continue to dominate in the forecast period. The factors the region holds the largest growth re the well-developed healthcare sector, increasing number of cancer patients, and increasing government expenditure on healthcare. In 2015, healthcare spending in the U.S. reached $3.2 trillion per person, 17.8% of the total GDP. The availability of funds for research, rising patient population and government support for the research and development of medication in Europe and Asia pushes the market towards growth. Europe holds the second-largest Bile Duct Cancer Market Share. Due to the continuous growth in the region like India and China, the market is experiencing high opportunities in the future. In India, the healthcare expenditure accounted for a CAGR of 5% and USD 68.6 from 2008 to 2015. Owing to the poor economy of Africa, the middle east and Africa are growing at a very low pace, but it is expected that the region will gain growth in the coming years.


Competitive Intensity Within The Industry  


The competitive landscape of the bile duct cancer market provides details by a competitor. Details that are included in the report are industry overview, financials, revenue gained, the potential of the market globally, investment in research and development, innovative market initiatives, global presence, production sites and facilities, production capacities, industry strengths and weaknesses, new product launch, product width and breadth, application dominance in the global field and others. The data points mentioned above provide the companies’ focus related to bile duct cancer market Growth. Major key players who are operating the market globally and forming new strategies for the market widening are



  • Pfizer Inc. in the U.S.

  • Hoffmann-La Roche Ltd in Europe

  • Bristol-Myers Squibb Company in the U.S.

  • Teva Pharmaceutical Industries Ltd.  In the Middle East

  • Eli Lilly and Company. In the U.S.

  • Sanofi in Europe

  • Fresenius Kabi AG in Europe

  • Mylan N.V. in the U.S.

  •  


Recent development  



  • Sam Brennan, age of 30, decided to run the Hampton Court Half Marathon on 20 February with six other friends to raise more than £2,600 for AMMF – the U.K.'s only cholangiocarcinoma charity in memory of his father, Derek.

  • The U.S. regulator has granted biliary tract cancer therapy Silmitasertib orphan drug destination and is expected to be accepted globally.


Report Overview 


The Bile Duct Cancer Market report includes a selective and substantial amount of information like market dynamics, scenarios, and opportunities during the forecast period. The  Bile Duct Cancer Market Forecast is also valued in the market, and based on the trends; the market is showcasing the development. Sub-segments of the market depict qualitative information, which pushes the market forward. The market's competitive landscape includes more entrants and the strategies made by the consistent key players. It also shows the market situation in the past years; the future situation is also predicted in the report. The recent development of the market is shown in the report to highlight the market's current scenario.


Key industrial segments 


By type



  • Intrahepatic

  • Extrahepatic


By diagnosis



  • Blood Tests

  • Abdominal Imaging

  • Surgery


By treatment



  • Chemotherapy

  • Radiotherapy.


By end-user



  • Hospital& Clinics

  • Academic Institutes



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Global Bile Duct Cancer Market is expected to exhibit a strong 9.2% CAGR over the forecast period from 2016 to 2023.

The growing awareness about cancer treatments is the major driver for the Bile Duct Cancer Market.

High costs of treatment and unavailability in many emerging countries are the key restraints on Global Bile Duct Cancer Market.

The Americas are the dominant force in the Global Bile Duct Cancer Market.

Leading players in the global bile duct cancer market include Pfizer, Bristol-Myers Squibb, and Eli Lilly, among others.